##fileformat=VCFv4.3
##fileDate=20250114
##source=BWA-MEM+GATK-HaplotypeCaller
##reference=GRCh38/hg38
##INFO=<ID=GENE,Number=1,Type=String,Description="Gene symbol">
##INFO=<ID=IMPACT,Number=1,Type=String,Description="Variant impact">
##INFO=<ID=CLINICAL,Number=1,Type=String,Description="Clinical significance">
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##FORMAT=<ID=DP,Number=1,Type=Integer,Description="Read depth">
##FORMAT=<ID=GQ,Number=1,Type=Integer,Description="Genotype quality">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	SAMPLE
chr1	69511	rs2691305	A	G	1289.77	PASS	GENE=.;IMPACT=.;CLINICAL=.	GT:DP:GQ	0/1:45:99
chr1	11796321	rs1057910	A	C	1456.77	PASS	GENE=MTHFR;IMPACT=MOD;CLINICAL=Warfarin sensitivity	GT:DP:GQ	0/1:52:99
chr1	11856378	rs1801133	G	A	892.77	PASS	GENE=MTHFR;IMPACT=MOD;CLINICAL=Homocysteinuria risk	GT:DP:GQ	0/1:38:99
chr1	55516888	rs1805087	A	G	934.77	PASS	GENE=MTR;IMPACT=MOD;CLINICAL=.	GT:DP:GQ	0/1:41:99
chr2	21231524	rs4988235	C	T	1678.77	PASS	GENE=MCM6;IMPACT=MOD;CLINICAL=Lactose intolerance	GT:DP:GQ	0/1:67:99
chr2	96919839	rs671	G	A	534.77	PASS	GENE=ALDH2;IMPACT=HIGH;CLINICAL=Alcohol flush	GT:DP:GQ	0/1:28:99
chr2	233693189	rs5030655	AAAG	A	2456.80	PASS	GENE=UGT1A1;IMPACT=HIGH;CLINICAL=Gilbert syndrome	GT:DP:GQ	0/1:89:99
chr3	37089111	rs121913530	C	T	678.77	PASS	GENE=MLH1;IMPACT=HIGH;CLINICAL=Lynch syndrome	GT:DP:GQ	0/1:31:99
chr3	49416656	rs1800460	C	T	567.77	PASS	GENE=TPMT;IMPACT=MOD;CLINICAL=Azathioprine sensitivity	GT:DP:GQ	0/1:25:99
chr3	184039268	rs1799853	C	T	812.77	PASS	GENE=CYP2C9;IMPACT=HIGH;CLINICAL=Warfarin sensitivity	GT:DP:GQ	0/1:36:99
chr4	55141055	rs1873778	A	G	567.77	PASS	GENE=PDGFRA;IMPACT=LOW;CLINICAL=.	GT:DP:GQ	0/1:25:99
chr5	1295113	rs16969968	G	A	1123.77	PASS	GENE=CHRNA5;IMPACT=MOD;CLINICAL=Nicotine dependence	GT:DP:GQ	0/1:50:99
chr5	35861068	rs1042713	A	G	623.77	PASS	GENE=ADRB2;IMPACT=MOD;CLINICAL=Asthma response	GT:DP:GQ	0/1:28:99
chr5	112827970	rs113994105	G	A	1123.77	PASS	GENE=APC;IMPACT=MOD;CLINICAL=.	GT:DP:GQ	0/1:50:99
chr6	26093141	rs1800562	G	A	1789.77	PASS	GENE=HFE;IMPACT=HIGH;CLINICAL=Hemochromatosis	GT:DP:GQ	0/1:80:99
chr6	160585129	rs10455872	G	A	1345.77	PASS	GENE=LPA;IMPACT=LOW;CLINICAL=Cardiovascular risk	GT:DP:GQ	0/1:60:99
chr7	87509329	rs1799998	A	G	456.77	PASS	GENE=ABCB1;IMPACT=LOW;CLINICAL=Drug response	GT:DP:GQ	0/1:20:99
chr7	117559590	rs1800888	A	G	823.77	PASS	GENE=CFTR;IMPACT=MOD;CLINICAL=.	GT:DP:GQ	0/1:37:99
chr8	18248755	rs1126809	T	C	467.77	PASS	GENE=NAT2;IMPACT=MOD;CLINICAL=Isoniazid metabolism	GT:DP:GQ	0/1:21:99
chr9	136139265	rs8175347	TAAA	T	2089.80	PASS	GENE=ABO;IMPACT=MOD;CLINICAL=.	GT:DP:GQ	0/1:93:99
chr10	94761900	rs61750900	T	C	978.77	PASS	GENE=CYP2C9;IMPACT=HIGH;CLINICAL=Phenytoin metabolism	GT:DP:GQ	0/1:44:99
chr10	96798749	rs4986893	G	A	1123.77	PASS	GENE=CYP2C19;IMPACT=HIGH;CLINICAL=Clopidogrel resistance	GT:DP:GQ	0/1:50:99
chr11	47380113	rs1800497	C	T	756.77	PASS	GENE=DRD2;IMPACT=MOD;CLINICAL=Antipsychotic response	GT:DP:GQ	0/1:34:99
chr11	67352689	rs267606617	CTGGA	C	3892.80	PASS	GENE=LRP5;IMPACT=HIGH;CLINICAL=Osteoporosis	GT:DP:GQ	0/1:174:99
chr12	21178615	rs2032582	A	T	934.77	PASS	GENE=ABCB1;IMPACT=MOD;CLINICAL=Drug response	GT:DP:GQ	0/1:42:99
chr12	21331549	rs1045642	A	G	1456.77	PASS	GENE=ABCB1;IMPACT=LOW;CLINICAL=Drug response	GT:DP:GQ	0/1:65:99
chr12	25398284	rs121913529	C	T	823.77	PASS	GENE=KRAS;IMPACT=HIGH;CLINICAL=Lung cancer	GT:DP:GQ	0/1:37:99
chr13	20763620	rs80359507	GAA	G	2156.80	PASS	GENE=GJB2;IMPACT=HIGH;CLINICAL=Deafness	GT:DP:GQ	0/1:96:99
chr13	32315474	rs80359550	AAAC	A	1856.80	PASS	GENE=BRCA2;IMPACT=HIGH;CLINICAL=Breast cancer	GT:DP:GQ	0/1:83:99
chr13	48919740	rs4149056	T	C	689.77	PASS	GENE=SLCO1B1;IMPACT=HIGH;CLINICAL=Statin myopathy	GT:DP:GQ	0/1:31:99
chr15	75011669	rs2470893	C	T	489.77	PASS	GENE=CYP1A1;IMPACT=LOW;CLINICAL=.	GT:DP:GQ	0/1:22:99
chr16	28883241	rs3745274	G	T	423.77	PASS	GENE=CYP2B6;IMPACT=HIGH;CLINICAL=Efavirenz metabolism	GT:DP:GQ	0/1:19:99
chr16	31107689	rs9934438	G	A	1234.77	PASS	GENE=VKORC1;IMPACT=MOD;CLINICAL=Warfarin sensitivity	GT:DP:GQ	0/1:55:99
chr17	7674220	rs1042522	G	C	1892.77	PASS	GENE=TP53;IMPACT=MOD;CLINICAL=benign	GT:DP:GQ	0/1:85:99
chr17	41197774	rs28897756	GAAA	G	2456.80	PASS	GENE=BRCA1;IMPACT=HIGH;CLINICAL=Breast/ovarian cancer	GT:DP:GQ	0/1:110:99
chr17	41223094	rs16942	C	T	1456.77	PASS	GENE=BRCA1;IMPACT=MOD;CLINICAL=.	GT:DP:GQ	0/1:65:99
chr17	41244936	rs80357906	G	A	623.77	PASS	GENE=BRCA1;IMPACT=HIGH;CLINICAL=Breast/ovarian cancer	GT:DP:GQ	0/1:28:99
chr17	41245466	rs80356898	G	A	934.77	PASS	GENE=BRCA1;IMPACT=HIGH;CLINICAL=Breast/ovarian cancer	GT:DP:GQ	0/1:42:99
chr19	15311788	rs2472297	C	T	567.77	PASS	GENE=CYP4F2;IMPACT=MOD;CLINICAL=Warfarin dose	GT:DP:GQ	0/1:25:99
chr19	44908684	rs429358	T	C	1234.77	PASS	GENE=APOE;IMPACT=HIGH;CLINICAL=Alzheimer risk	GT:DP:GQ	0/1:55:99
chr19	44908822	rs7412	C	T	789.77	PASS	GENE=APOE;IMPACT=HIGH;CLINICAL=protective	GT:DP:GQ	0/1:35:99
chr20	62053989	rs6025	C	T	1567.77	PASS	GENE=F5;IMPACT=HIGH;CLINICAL=Factor V Leiden	GT:DP:GQ	0/1:70:99
chr22	19956059	rs2267437	G	C	789.77	PASS	GENE=COMT;IMPACT=MOD;CLINICAL=Pain sensitivity	GT:DP:GQ	0/1:35:99
chr22	42523943	rs4680	G	A	612.77	PASS	GENE=CYP1B1;IMPACT=MOD;CLINICAL=.	GT:DP:GQ	0/1:27:99
chrX	31496631	rs104894790	C	T	612.77	PASS	GENE=DMD;IMPACT=HIGH;CLINICAL=Duchenne muscular dystrophy	GT:DP:GQ	0/1:27:99
chrX	70360989	rs1131691	G	A	534.77	PASS	GENE=OPN1MW;IMPACT=HIGH;CLINICAL=Color blindness	GT:DP:GQ	0/1:24:99
chrX	153234893	rs3810526	C	T	423.77	PASS	GENE=G6PD;IMPACT=HIGH;CLINICAL=G6PD deficiency	GT:DP:GQ	0/1:19:99
chr1	1000001	rs12345678	A	T	1000.00	PASS	GENE=TEST1;IMPACT=HIGH;CLINICAL=Test variant 1	GT:DP:GQ	0/1:45:99
chr1	1000002	rs12345679	C	G	1100.00	PASS	GENE=TEST2;IMPACT=MOD;CLINICAL=Test variant 2	GT:DP:GQ	0/1:50:99
chr1	1000003	rs12345680	T	A	1200.00	PASS	GENE=TEST3;IMPACT=LOW;CLINICAL=Test variant 3	GT:DP:GQ	0/1:55:99
chr2	2000001	rs12345681	G	C	1300.00	PASS	GENE=TEST4;IMPACT=HIGH;CLINICAL=Test variant 4	GT:DP:GQ	0/1:60:99
chr2	2000002	rs12345682	A	T	1400.00	PASS	GENE=TEST5;IMPACT=MOD;CLINICAL=Test variant 5	GT:DP:GQ	0/1:65:99
chr3	3000001	rs12345683	C	G	1500.00	PASS	GENE=TEST6;IMPACT=LOW;CLINICAL=Test variant 6	GT:DP:GQ	0/1:70:99
chr3	3000002	rs12345684	T	A	1600.00	PASS	GENE=TEST7;IMPACT=HIGH;CLINICAL=Test variant 7	GT:DP:GQ	0/1:75:99
chr4	4000001	rs12345685	G	T	1700.00	PASS	GENE=TEST8;IMPACT=MOD;CLINICAL=Test variant 8	GT:DP:GQ	0/1:80:99
chr4	4000002	rs12345686	A	C	1800.00	PASS	GENE=TEST9;IMPACT=LOW;CLINICAL=Test variant 9	GT:DP:GQ	0/1:85:99
chr5	5000001	rs12345687	C	T	1900.00	PASS	GENE=TEST10;IMPACT=HIGH;CLINICAL=Test variant 10	GT:DP:GQ	0/1:90:99
chr5	5000002	rs12345688	G	A	2000.00	PASS	GENE=TEST11;IMPACT=MOD;CLINICAL=Test variant 11	GT:DP:GQ	0/1:95:99
chr6	6000001	rs12345689	T	C	2100.00	PASS	GENE=TEST12;IMPACT=LOW;CLINICAL=Test variant 12	GT:DP:GQ	0/1:100:99
chr6	6000002	rs12345690	A	G	2200.00	PASS	GENE=TEST13;IMPACT=HIGH;CLINICAL=Test variant 13	GT:DP:GQ	0/1:105:99
chr7	7000001	rs12345691	C	A	2300.00	PASS	GENE=TEST14;IMPACT=MOD;CLINICAL=Test variant 14	GT:DP:GQ	0/1:110:99
chr7	7000002	rs12345692	G	T	2400.00	PASS	GENE=TEST15;IMPACT=LOW;CLINICAL=Test variant 15	GT:DP:GQ	0/1:115:99
chr8	8000001	rs12345693	T	G	2500.00	PASS	GENE=TEST16;IMPACT=HIGH;CLINICAL=Test variant 16	GT:DP:GQ	0/1:120:99
chr8	8000002	rs12345694	A	C	2600.00	PASS	GENE=TEST17;IMPACT=MOD;CLINICAL=Test variant 17	GT:DP:GQ	0/1:125:99
chr9	9000001	rs12345695	C	T	2700.00	PASS	GENE=TEST18;IMPACT=LOW;CLINICAL=Test variant 18	GT:DP:GQ	0/1:130:99
chr9	9000002	rs12345696	G	A	2800.00	PASS	GENE=TEST19;IMPACT=HIGH;CLINICAL=Test variant 19	GT:DP:GQ	0/1:135:99
chr10	10000001	rs12345697	T	C	2900.00	PASS	GENE=TEST20;IMPACT=MOD;CLINICAL=Test variant 20	GT:DP:GQ	0/1:140:99
